BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Third Rock Ventures 

29 Newbury Street
3rd Floor
Boston  Massachusetts  02116  U.S.A.
Phone: 617-585-2000 Fax: 617-859-2891


SEARCH JOBS




Industry
Services






 Company News
SV Life Sciences And Third Rock Ventures Launch Transformative Medical Device Company Cibiem With $10 Million Series 9/26/2014 1:59:37 PM
Two San Francisco Startups, Element Science And Nurix, Reap Cash From Third Rock Ventures' Rich Funding Round 4/24/2014 7:33:47 AM
Third Rock Ventures Launches Gene-Therapy Startup, Voyager Therapeutics, With $45 Million Series A In Pocket 2/12/2014 7:03:02 AM
Third Rock Ventures May Have the Cure to Get Groundbreaking Therapies to Patients AND Revive Biotech in Boston 8/29/2013 7:37:28 AM
Third Rock Ventures Taps Alnylam Pharmaceuticals (ALNY) CEO, Genzyme Corporation (GENZ)-ImClone Systems (LLY) Vets, as Venture Partners 5/14/2013 7:57:36 AM
Third Rock Ventures Stocks Up With $516 Million New Fund, Looks to Start 16 Companies 3/25/2013 8:18:33 AM
Third Rock Ventures' Bet on Lotus Tissue Repair Generates Big Return, Up to $325 Million 2/27/2013 8:23:34 AM
Third Rock Ventures Launches Jounce Therapeutics With $47 Million 2/14/2013 7:45:55 AM
Third Rock Ventures Appoints Mark L. Perry and Uday N. Kumar, M.D., to Entrepreneur-in-Residence Positions in West Coast Office 12/19/2012 7:10:50 AM
Third Rock Ventures Appoints Personalized Medicine Expert Felix W. Frueh, Ph.D., as Entrepreneur-in-Residence 10/2/2012 10:16:41 AM
12